⌘K

Login Start Free

Home/Insiders/Nickson Philip

NP

SEC Insider//CIK 0001911369

Nickson Philip

CIK 00019113691 companyBOSTON, MA

Transactions

10

Companies

1

Filings

7

CIK

0001911369

Recent Transactions

10 trades

Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-04-09$17.69/sh−5,845→ 55,000 total
Sale
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-01-05$15.17/sh−3,155→ 60,845 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2026-01-02+28,000→ 64,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2026-01-02+126,000→ 126,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2025-01-02+161,000→ 161,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Common Stock
2025-01-02+36,000→ 36,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2024-06-03+40,000→ 40,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2024-01-02+109,000→ 109,000 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2023-01-03+123,650→ 123,650 total
Award
Monte Rosa Therapeutics, Inc.$GLUE
Stock Option (Right to Buy)
2022-03-01+70,600→ 70,600 total

Companies

1

Monte Rosa Therapeutics, Inc.
Chief Business & Legal Officer
$GLUE

Recent Filings

7

Address

MONTE ROSA THERAPEUTICS, INC. 321 HARRISON AVENUE, SUITE 900

BOSTON, MA, 02118

View on SEC.gov